Skip to main content
. 2006 Oct 15;56(5):621–630. doi: 10.1136/gut.2006.106674

graphic file with name gt106674.f2.jpg

Figure 2 Immunohistochemistry and macroscopic appearances of oesophageal ulcers 6 days after serum response factor (SRF) gene therapy. Scale bar, 100 μm. (A–C) Granulation tissues stained with the antibody against smooth muscle (SM) α‐actin showing an increase in the number of SM α‐actin expression cells due to local upregulation of SRF (SRF+) and a decrease due to local knockdown of SRF (SRF−). (D–F) Granulation tissues stained with the antibody against smoothelin showing an increase in the number of smooth muscle cells due to local upregulation of SRF (SRF+) and a decrease due to local knockdown of SRF (SRF−). (G–I) Granulation tissues stained with the antibody recognising His tag showing specific nuclear staining in the rats that received SRF+ plasmid injection. (J–L) Macroscopic pictures of dissected oesophagus showing reduced ulcer size by local upregulation of SRF (SRF+) and delayed healing due to SRF deficiency (SRF−).